Navigation Links
Registration Open for OpenClinica European Summit - April 14, 2009
Date:1/20/2009

Event in Brussels to bring together community around OpenClinica open source clinical trial software.

Brussels, Belgium (PRWEB) January 20, 2009 -- Akaza Research announces the first annual OpenClinica European Summit. The event will be held on April 14, 2009 in Brussels, Belgium and bring together users, developers, and leading service providers of the OpenClinica open source electronic data capture (EDC) software.

The Summit is open to the public and will feature engaging presentations by clinical trial sponsors, contract research organizations, academic and government research institutions, and providers of EDC-related services. Conference session formats will include case studies, panel discussions, sessions for end-users as well as system administrators and developers. The keynote presentation will be given by Akaza's CEO Cal Collins.

"This is an exciting time for OpenClinica users in Europe," said Mr. Collins. "The rapid growth in the software's popularity and use in clinical trials by European organizations should make this a very productive and informative event. I look forward to engaging with our European community about OpenClinica's developments and direction."

For more information and to register for the event, see http://www.openclinica.org/European_Summit.html.

Early bird deadline for registration is January 30, 2009.

About OpenClinica®
OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical data management (CDM). OpenClinica facilitates study protocol configuration, data collection via electronic case re
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2

Related biology technology :

1. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
2. Anacor Files Registration Statement for Initial Public Offering
3. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
4. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
5. SyntheMed Files Universal Shelf Registration
6. National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC
7. Reliant Pharmaceuticals Announces the Filing of Registration Statement on Form S-1 For an Initial Public Offering
8. /CORRECTION//- RxElite Temporarily Suspends Sales Under Its Registration Statement
9. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
10. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
11. Marketing and Meeting Details (M2D) Offers Customized Convention Registration and Management Tool to Clients Inside and Outside of Pharma/Biotech
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Registration Open for OpenClinica European Summit - April 14, 2009
Registration Open for OpenClinica European Summit - April 14, 2009
(Date:12/11/2009)... Researchers have discovered a new explanation for differences in the ... of a certain gene, the more serious the handicap. The ... suspected that it is the amount of copies of the ... in the American Journal of Human Genetics , and ... Froyen connected to VIB, a life sciences research institute in ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer ... center in the,US, the Tulane Cancer Center, ... phase III clinical study of Alpharadin in ... cancer,(CRPC) that has metastasized to the skeleton. ... (ALpharadin in SYMptomatic Prostate CAncer) study is ...
(Date:12/11/2009)... Inc. (TSX:ONC, NASDAQ: ONCY ) ("Oncolytics" or the ... Warrander to the role of Senior Vice President, ... will be responsible for the execution of the ... Thompson, President and CEO of Oncolytics. "Having reached ... 3 trial examining REOLYSIN in combination with paclitaxel ...
(Date:12/10/2009)... Dec. 10 Microban International, Ltd., ... protection, has partnered with Sharp Imaging and ... Sharp Electronics, to incorporate it,s third generation ... calculators. Infused into the calculator keys during ... the growth of damaging bacteria on the ...
Breaking Biology Technology:Amount of gene surplus determines severity of mental retardation in males 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology 2
... LAFAYETTE, Ind. - Fingerprints can reveal critical evidence, as ... new technology developed at Purdue University that detects trace ... in the prints. , The new technology also can ... a difficult task for current optical forensic methods. , ...
... University of Chicago scientists have induced electrons in the ... them into a smaller volume. This has the potential ... power. , "Slowing down the cooling of these electronsin ... a better infrared laser source," said Philippe Guyot-Sionnest, Professor ...
... Savient,Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced that ... present a corporate update at the upcoming Lazard Capital ... to begin on Tuesday, November 18, 2008 at,9:25 a.m. ... Regis Hotel in New,York City November 18-19, 2008., ...
Other Biology Technology:Fingerprints provide clues to more than just identity 2New research expected to improve laser devices and make photovoltaics more efficient 2Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th 2
(Date:12/11/2009)... an associate professor of anthropology at the University of ... Kenya to understand how violence shapes the health of ... of her and her colleagues, research," Documenting the health ... northern Kenya: A conceptual framework," is currently published in ... , in collaboration with the British medical journal the ...
(Date:12/11/2009)... have traditionally been limited by the seasons, ... can be short. Thanks to researchers and ... introduced that offer growers the ability to ... bonuses for both producers and consumers. Fresh ... called "primocane-fruiting", which bear fruit on current-season ...
(Date:12/11/2009)... of Iowa researchers have found the existence of a ... on to find the genetic cause, which investigators hope ... The findings appeared in the Nov. 9 issue of ... located within the retina, is an area of high-resolution ... for example. This area is damaged in more common ...
Breaking Biology News(10 mins):UA-led study grapples with health effects of low-intensity warfare 2New management methods extend blackberry season 2New inherited eye disease discovered 2Teens May Not Benefit from Pap Tests 53010 1Teens May Not Benefit from Pap Tests 53010 2Teens May Not Benefit from Pap Tests 53010 3First genetically engineered malaria vaccine to enter human trials 9401 1First genetically engineered malaria vaccine to enter human trials 9401 2President Takes Illinois Womans Tough Health Care Questions at AARP Town Hall 53003 1President Takes Illinois Womans Tough Health Care Questions at AARP Town Hall 53003 2
... pinkish-purple ornamental flower, just patented by Cornell, can last for ... garden, it blooms all summer long in the cooler, northern ... new hybrid of the Inca lily ( Alstroemeria ), which ... that is set apart by its lavender-lilac flower color (which ...
... device designed to eliminate mistakes made while mixing compounds ... identifying the proper formulations of seven intravenous drugs. ... an 18-month period in a test at C.S. Mott ... by using the technology, said Jim Stevenson, associate dean ...
... Philadelphia, PA, January 8, 2008 The field of ... potential approaches to treatment. From the introduction of ... the U.S. Food and Drug Administration have had, at ... the dopamine D2 receptor. The introduction of clozapine ...
Other Biology News:Cornell patents a pink lily look-alike that blooms all summer long 2Device prevents potential errors in children's medications 2New treatment mechanisms for schizophrenia 2New treatment mechanisms for schizophrenia 3